Chief Financial Officer · Bicara Therapeutics Inc. · Common Stock
Side
SELL
Value
$168K
Shares
9,200
Price
$18.31
Executed
Dec 22, 2025
Disclosed
Dec 23, 2025
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Dec 22 executedDec 23, 2025 disclosed
BCAX · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+4 / 15
2 prior trades recorded in this security
Frequency & clustering+5 / 15
1 other actor traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Hyep Ivan filed this Form 4 reporting a open-market sale of BCAX on Dec 22, 2025. It became public on Dec 23, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Financial Officer
Hyep Ivancik:0002034668
Issuer
Bicara Therapeutics Inc.cik:0002023658
Revision history · 0
No field has changed since this record was first ingested.
